Daniel Lunz

Chief Executive Officer at Capsulomics.

Raised on Capsulomics filings

$2.4M

of $3M offered across 1 Form D filing

Company

Healthcare · Halethorpe, MD

Esophageal cancer risk test for Barrett's patients

Esophageal cancer risk test for Barrett's patients

Capsulomics Form D filings
Filed	Security	Sold of offered	Filing
Mar 19, 2025	Other	$2.4M/ $3M	Form D/A

Also named on Capsulomics filings